Cargando…

α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine

As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (P...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Sa, Zhong, Chunting, Wang, Weiwei, Jia, Yongguang, Wang, Lin, Ren, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415174/
https://www.ncbi.nlm.nih.gov/pubmed/30966226
http://dx.doi.org/10.3390/polym10020190
_version_ 1783403129764577280
author Liu, Sa
Zhong, Chunting
Wang, Weiwei
Jia, Yongguang
Wang, Lin
Ren, Li
author_facet Liu, Sa
Zhong, Chunting
Wang, Weiwei
Jia, Yongguang
Wang, Lin
Ren, Li
author_sort Liu, Sa
collection PubMed
description As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (PR-(SD-Ag)) was then prepared by loading SD-Ag onto PR with different mass ratios. The loading capacity and the encapsulation efficiency were 90% at a mass ratio of 1:1 of PR and SD-Ag. SD-Ag was released stably and slowly within 6 d in vitro, and its cumulative release reached more than 85%. The mechanism of PR loading SD-Ag might be that SD-Ag attached to the edge of α-CD through hydrogen bonding. PR-(SD-Ag) showed a higher light stability than SD-Ag and held excellent antibacterial properties against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus).
format Online
Article
Text
id pubmed-6415174
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64151742019-04-02 α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine Liu, Sa Zhong, Chunting Wang, Weiwei Jia, Yongguang Wang, Lin Ren, Li Polymers (Basel) Article As a drug carrier, polyrotaxane (PR) has been used for targeted delivery and sustained release of drugs, whereas silver sulfadiazine (SD-Ag) is an emerging antibiotic agent. PR was synthesized by the use of α-cyclodextrin (CD) and poly(ethylene glycol) (PEG), and a specific antibacterial material (PR-(SD-Ag)) was then prepared by loading SD-Ag onto PR with different mass ratios. The loading capacity and the encapsulation efficiency were 90% at a mass ratio of 1:1 of PR and SD-Ag. SD-Ag was released stably and slowly within 6 d in vitro, and its cumulative release reached more than 85%. The mechanism of PR loading SD-Ag might be that SD-Ag attached to the edge of α-CD through hydrogen bonding. PR-(SD-Ag) showed a higher light stability than SD-Ag and held excellent antibacterial properties against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). MDPI 2018-02-14 /pmc/articles/PMC6415174/ /pubmed/30966226 http://dx.doi.org/10.3390/polym10020190 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Sa
Zhong, Chunting
Wang, Weiwei
Jia, Yongguang
Wang, Lin
Ren, Li
α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title_full α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title_fullStr α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title_full_unstemmed α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title_short α-Cyclodextrins Polyrotaxane Loading Silver Sulfadiazine
title_sort α-cyclodextrins polyrotaxane loading silver sulfadiazine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415174/
https://www.ncbi.nlm.nih.gov/pubmed/30966226
http://dx.doi.org/10.3390/polym10020190
work_keys_str_mv AT liusa acyclodextrinspolyrotaxaneloadingsilversulfadiazine
AT zhongchunting acyclodextrinspolyrotaxaneloadingsilversulfadiazine
AT wangweiwei acyclodextrinspolyrotaxaneloadingsilversulfadiazine
AT jiayongguang acyclodextrinspolyrotaxaneloadingsilversulfadiazine
AT wanglin acyclodextrinspolyrotaxaneloadingsilversulfadiazine
AT renli acyclodextrinspolyrotaxaneloadingsilversulfadiazine